Ki-67 Antigen
Research News and Information

Sunday, November 22, 2009

Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1).

29 Nov 2009 Osteosarcomas are the most prevalent primary bone tumors found in pediatric patients. To understand their molecular etiology, cell culture models are used to define disease mechanisms under controlled conditions. Many osteosarcoma cell lines (e.g., ... Read more...

Immunophenotypic variations in mantle cell lymphoma.

30 Oct 2009 Mantle cell lymphoma (MCL) expresses pan-B-cell antigens and is usually CD5+/CD10-/CD23-/FMC7+. In this study, we evaluated 52 patients with confirmed diagnoses of MCL and identified variant immunophenotypes in 21 patients (19/48 classical and 2/4 ... Read more...

Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats.

30 Oct 2009 BACKGROUND: Chemoprevention utilizing dietary agents is an effective means to slow the development of prostate cancer. We evaluated the potential additive and synergistic effects of genistein and resveratrol for suppressing prostate cancer in the ... Read more...

Latest indexed articles for 'Ki-67 Antigen'

These are the very latest articles for this heading:

• Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1). 29 Nov 2009
• Immunophenotypic variations in mantle cell lymphoma. 30 Oct 2009
• Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats. 30 Oct 2009
• Comparison of ACINUS, caspase-3, and TUNEL as apoptotic markers in determination of tumor growth rates of clinically localized prostate cancer using image analysis. 30 Oct 2009
• Aurora B expression in post-puberal testicular germ cell tumours. 30 Oct 2009
• Assessment of "grading" with Ki-67 and c-kit immunohistochemical expressions may be a helpful tool in management of patients with flat epithelial atypia (FEA) and columnar cell lesions (CCLs) on core breast biopsy. 30 Oct 2009
• Tanycytic ependymoma of the filum terminale with pleomorphic giant cells. 25 Oct 2009
• Radiopathological characteristics of cerebellar malignant glioma in adults. 25 Oct 2009
• Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases. 25 Oct 2009
• Salivary analysis of oral cancer biomarkers. 4 Oct 2009
• The expression of vascular endothelial growth factor in skeletal muscle of patients with sleep disorders. 29 Sep 2009
• A scoring system for histopathologic and immunohistochemical evaluations of uterine leiomyosarcomas. 29 Sep 2009
• Radiofrequency ablation and dilated columnar-lined esophagus. 29 Sep 2009
• CD8+ cell depletion of SHIV89.6P-infected macaques induces CD4+ T cell proliferation that contributes to increased viral loads. 26 Sep 2009
• Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. 20 Sep 2009
• Immunohistochemical study of pig retinal development. 19 Sep 2009
• Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. 14 Sep 2009
• Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate. 13 Sep 2009
• AP2gamma regulates basal progenitor fate in a region- and layer-specific manner in the developing cortex. 11 Sep 2009
• An integrin alpha(v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression. 4 Sep 2009

See a longer list of these articles.

Technical information about 'Ki-67 Antigen'

Definition: A CELL CYCLE and tumor growth marker which can be readily detected using IMMUNOCYTOCHEMISTRY methods. Ki-67 is a nuclear antigen present only in the nuclei of cycling cells.

Registry Number: 0

Descriptor UI: D019394

Alternative terms: Ki-67 Antigen; Antigen, Ki-67; Ki 67 Antigen; MIB-1 Protein; MIB 1 Protein; MIB-1 Antigen; Antigen, MIB-1; MIB 1 Antigen; Antigen Ki-67; Antigen Ki 67; Ki-67, Antigen; Antigen Ki67; Ki67, Antigen;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; biosynthesis; blood; cerebrospinal fluid; classification; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacology; physiology; poisoning; radiation effects; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications;

Tree Number: D12.776.660.625.500; D23.050.290.500; D23.101.840.400;

Online Note: use KI-67 ANTIGEN (NM) to search ANTIGEN KI67 1988-96

History Note: 97; was ANTIGEN KI67 (NM) 1988-96

Technical Notes: X ref MIB-1 ANTIGEN: MIB-1 antibody is available in the SCR